SCHEMBL8775995

SCHEMBL8775995

CC(=O)Oc1ccc2c(c1)C[C@@H](C)[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.58
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
ESR1 P03372 2/20 0.41
OPRM1 P35372 2/20 0.41
PGR P06401 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
AR P10275 1/20 0.41
CHRM1 P11229 1/20 0.41
TBXA2R P21731 1/20 0.41
ADRA1A P35348 1/20 0.41
SLC6A3 Q01959 1/20 0.41
ATM Q13315 1/20 0.41
CYP3A4 P08684 3/20 0.41
STS P08842 5/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5679460 0.90 AKR1C3 (0.58) AKR1C3TSHRMAPK1HSD17B10SMN1; SMN2
SCHEMBL9830530 0.84 HSD17B10 (0.51) AKR1C3TSHRMAPK1HSD17B10LMNA
SCHEMBL8776090 0.83 AKR1C3 (0.79) AKR1C3TSHRMAPK1HSD17B10SMN1; SMN2
SCHEMBL8775986 0.83 CYP3A4 (0.54) AKR1C3HSD17B10SMN1; SMN2LMNAESR1
SCHEMBL8775742 0.82 ESR1 (0.52) AKR1C3HSD17B10SMN1; SMN2LMNAESR1
SCHEMBL5191077 0.80 LMNA (0.52) AKR1C3TSHRMAPK1HSD17B10SMN1; SMN2
SCHEMBL14558089 0.80 LMNA (0.52) AKR1C3TSHRMAPK1HSD17B10SMN1; SMN2
SCHEMBL8986623 0.75 HSD17B10 (0.53) AKR1C3TSHRMAPK1HSD17B10LMNA
SCHEMBL8775793 0.75 AKR1C3 (0.49) AKR1C3TSHRMAPK1HSD17B10SMN1; SMN2
SCHEMBL9747578 0.74 AKR1C3 (0.77) AKR1C3TSHRMAPK1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0719276-B1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE US HEALTH (US) 1997-11-26 EP disclosed
US-5554603-A 11,17-DINITRATES; USE TO ACHIEVE ESTROGENIC EFFECT IN FEMALE MAMMALS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-09-10 US disclosed
WO-1995007925-A1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-03-23 WO disclosed
US-RE34136-E Morning-after contraceptives SRI INTERNATIONAL (US) 1992-12-01 US disclosed
US-4705783-A 9α, 11β-substituted and 11β-substituted estranes SRI INTERNATIONAL (US) 1987-11-10 US disclosed
WO-1987000175-A1 9alpha, 11beta-SUBSTITUTED AND 11beta-SUBSTITUTED ESTRANES SRI INTERNATIONAL (US) 1987-01-15 WO disclosed